Understanding GLP

Beyond Diabetes: Weight Management While initially designed for diabetes, GLP-1 agonists have shown significant effectiveness in promoting weight loss . This is due to their impact on appetite and gastric emptying. This is why many non-diabetic people are using these drugs.

Originally developed to treat diabetes, glucagon-like peptide-1 ( GLP-1 ) agonists have recently dominated media coverage due to their potent effects on weight loss . Preliminary research has also suggested that these drugs may also have a protective role in other body systems and improve health outcomes outside of height loss . Kieren Mather, MD, PhD, from Eli Lilly … Continue reading GLP-1 ...
Understanding the Benefit of Combining GLP

These findings are in line with the current work (5) because they suggest the combination of GLP-1 agonist plus exercise may be more beneficial for overall health vs. either treatment alone. There has been much excitement recently for using semaglutide as a weight loss drug. However, this study among others raises the idea that timing may matter.
Abstract Recent literature shows that GLP-1 receptor agonists are highly effective for weight loss and improving metabolic and cardiovascular health, often surpassing the results of lifestyle interventions alone, such as exercise and diet modification. However, long-term weight maintenance is more successful when exercise is included, as stopping GLP-1 therapy alone often leads to weight ...

Useful Notes on Understanding Glp 1 Agonists More Than Just Weight Loss Workout
GLP-1 drugs influence more than the gut and the weight . Research shows that they impact the health of the heart, brain, bones and muscles.
Currently, there are more than 1 billion people worldwide with obesity, many of whom also have type 2 diabetes mellitus or prediabetes. 1 The recent emergence of novel therapies that drive weight ...

Overview of Understanding Glp 1 Agonists More Than Just Weight Loss Workout
The amount of muscle lost in most people who take GLP-1 drugs is similar to what's seen in people who lose weight through diet alone, and in both cases it can be minimized with balanced food choices and exercise ( more on that below).
This Perspective describes the challenges of prescribing exercise for weight loss , with and without the use of glucagon-like peptide 1 ( GLP-1 ) receptor agonists , and discusses strategies clinicians can use to improve adherence to exercise recommendations.

Key Details About Understanding Glp 1 Agonists More Than Just Weight Loss Workout
GLP-1 receptor agonists (RA), such as Ozempic and Mounjaro, were initially designed to help manage blood sugar in type 2 diabetes. Now, they are reshaping the landscape of obesity treatment and metabolic health with impacts that go far beyond the scale. "About 1 in 8 adult Americans has already used GLP-1 drugs.





He also explained why exercise remains potent medicine for anyone trying to manage their weight . What prompted you to write the JAMA piece? I'm interested in the effects of physical activity on health and weight , and just about everybody is now interested in GLP-1s because they've been transformative for many people.